NLM Digital Collections


Search Constraints

Start Over You searched for: Subjects Sample Size Remove constraint Subjects: Sample Size

Search Results

2. Consideration of uncertainty in making benefit-risk determinations in medical device premarket approvals, de novo classifications, and humanitarian device exemptions: guidance for industry and Food and Drug Administration staff

3. S3A guidance: note for guidance on toxicokinetics : the assessment of systemic exposure in toxicity studies : focus on microsampling : questions and answers